Mandate

Vinge advised Dagon in relation to expansion of its property portfolio in Gothenburg

November 02, 2010

Dagon has acquired the industrial property designated as Sävenäs 170:13 in Gothenburg from L-Å Eveberg Fastighetsutveckling AB. The property is situated adjacent to Dagon’s property designated as Sävenäs 170:14 on von Utfallsgatan in Gothenburg. The purchase price was based on a total underlying property value of SEK 16. 9 million. Completion was scheduled to occur on 1 November 2010. The acquisition was effected through a share transfer of the real estate holding company.

Dagon also acquired two properties designated as Tuve 86:2 and Tynnered 1: 15 in Gothenburg. The properties are currently fully let and annual rental income amounts to approximately SEK 6.4 million. The purchase price was based on a total underlying property value of SEK 72.5 million. Completion was scheduled to occur on 1 November 2010.

Dagon AB (publ) is a property development company with an estate portfolio with a market value of approximately SEK 5 billion. The portfolio primarily consists of commercial properties and some project development properties in southern and central Sweden. Dagon AB is listed on NASDAQ OMX Stockholm.

Vinge’s team consisted of Olof Jisland and Ulf Käll.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025